← All trials
NCT00801814
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2006
- Primary completion
- May 1, 2006
- Completion date
- Aug 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 6 / —
- Source
- AACT · pre-existing
Sponsors
- Glycemic Index Laboratories, IncLead sponsor
- Glycemic Index Laboratories, IncOverall official - principal investigator
- Glycemic Index Laboratories, IncStudy director
- InovoBiologic Inc.Collaborator
- Canadian Center for Functional MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.